Lindsay Kelly
Family · Wilmington, DENPI 1265815526
Payments from drug & device makers
Across 180 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$568
- AstraZeneca$344
- Pfizer$249
- Lilly USA, LLC$215
- Amgen$198
- AbbVie$194
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,995100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 35 | $568 |
| AstraZeneca | 18 | $344 |
| Pfizer | 12 | $249 |
| Lilly USA, LLC | 14 | $215 |
| Amgen | 19 | $198 |
| AbbVie | 12 | $194 |
| Merck | 12 | $192 |
| Novo Nordisk | 11 | $183 |
| Bayer | 11 | $177 |
| Boehringer Ingelheim | 8 | $128 |
| Abbott | 4 | $92 |
| Sanofi-aventis U.S. LLC | 3 | $66 |
| Astellas Pharma US Inc | 3 | $49 |
| Novartis | 2 | $31 |
| Shield Therapeutics Inc | 2 | $30 |
| Vertos Medical, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$2,995 in reported general payments places this provider in the 85th percentile of 523 family providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 66 | $74,882 |
| OzempicSemaglutide | 72 | $68,111 |
| FarxigaDapagliflozin Propanediol | 40 | $54,013 |
| RybelsusSemaglutide | 22 | $44,765 |
| EliquisApixaban | 43 | $37,438 |
| XareltoRivaroxaban | 23 | $27,698 |
| JanuviaSitagliptin Phosphate | 18 | $23,157 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $21,658 |
| Repatha SureclickEvolocumab | 31 | $19,821 |
| MounjaroTirzepatide | 11 | $19,112 |
| LinzessLinaclotide | 14 | $11,414 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 33 | $10,534 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 33 | $7,300 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $6,811 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $6,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $183 | $112,87594 claims |
| Boehringer IngelheimJardiance | $128 | $74,88266 claims |
| AstraZenecaFarxiga | $344 | $54,01340 claims |
| PfizerEliquis, Abrysvo | $249 | $47,97376 claims |
| GSKTrelegy Ellipta, Shingrix | $568 | $28,95855 claims |
| MerckJanuvia | $192 | $23,15718 claims |
| Lilly USA, LLCMounjaro | $215 | $19,11211 claims |
| AbbVieLinzess | $194 | $11,41414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 523 family providers in Delaware.
Other family in Wilmington
- Tracy EstesWilmington$59K
- Jodi KahanWilmington$21K
- Elizabeth Sharp-AsiyoWilmington$13K
- Shannon HogateWilmington$10K
- Carolyn BarrettWilmington$10K
- Gloria DiazWilmington$8K
- Amy HitchensWilmington$8K
- Emmanuel AntonioWilmington$7K
- Stephanie Evans MitchellWilmington$6K
- Sidonie SalmonWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.